Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenocarcinoma
Researchers from Medical University of South Carolina report details of new studies and findings in the area of adenocarcinoma
May 4th, 2008
According to recent research published in the Journal of Thoracic and Cardiovascular Surgery, "We hypothesized that clinical outcome of resected early-stage adenocarcinoma of the lung can be predicted by the expression of a few critically important genes as measured by quantitative real-time reverse-transcriptase polymerase chain reaction in formalin-fixed paraffin-embedded primary tumors. Twenty-two prognostic genes for the metastatic phenotype were identified through complementary DNA microarray analysis of 4 cancer cell lines and bioinformatics analysis." "Expression levels of a subset of these genes (n = 13) were measured by real-time time...
Source: Pharma Investments, Ventures & Law Weekly (2008-05-04)
|
